"No new investor is confident to buy, as there have been countless hiccups, excessive down ramping"Funny, I would read that in the reverse - that investors are leery because of baseless upramping that has led nowhere.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%